一种GAD1抑制剂通过Wnt/β-catenin信号通路抑制骨肉瘤的生长
Changchun Jian1,2, Ben Wang1,2, Hai Mou1,2
1Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Heliyon
|May 28, 2024
概括
谷氨酸脱碳酶1 (GAD1),一个GABAergic系统标记物,在骨髓瘤 (OS) 中被上调. 它的抑制剂,3-默卡普托酸 (3-MPA) 通过抑制Wnt/β-catenin通路,显著抑制了OS生长.
科学领域:
- 在瘤学瘤学.
- 神经科学是一个神经科学.
- 生物化学 生物化学
背景情况:
- 谷氨酸脱碳酶1 (GAD1) 是GABAergic系统中的一个关键酶,主要存在于中枢神经系统.
- 异常的GAD1表达与促进各种癌症瘤细胞生长有关.
- 在骨髓瘤 (OS) 的发展和进展中GAD1的具体作用以前尚不清楚.
研究的目的:
- 为了研究GAD1在骨髓瘤 (OS) 组织中的表达状态.
- 为了评估GAD1抑制剂,3-默卡普托普罗酸 (3-MPA) 在OS的治疗潜力.
- 阐明3-MPA影响OS生长的潜在分子机制.
主要方法:
- 在OS患者数据 (R2数据库) 和组织 (免疫组织化学) 中分析GAD1表达.
- 在体外评估3-MPA对OS细胞活力,殖民地形成和细胞周期的影响.
- 在瘤携带裸体小鼠模型中体内评估3-MPA的疗效.
主要成果:
- 与相邻的正常组织相比,OS组织中的GAD1表达显著上调.
- 西方涂抹证实了OS细胞与人类骨质母细胞中的高GAD1水平.
- 3-MPA在体外和体内都显著抑制了OS细胞生长.
- 3-MPA治疗导致β-catenin和cyclin D1的抑制,使Wnt/β-catenin通路失活.
结论:
- 骨肉瘤表现出GABAergic标记物GAD1.1的表达增加.
- GAD1抑制剂3-MPA有效地降低了骨髓瘤的生长.
- 抑制Wnt/β-catenin通路是3-MPA在OS中的抗瘤作用的关键机制.
相关概念视频
02:54Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
01:16TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:20The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K